Cargando…

Efficacy of brief intervention for drug misuse in primary care facilities: systematic review and meta-analysis protocol

INTRODUCTION: Drug misuse is associated with significant global morbidity, mortality, economic costs and social costs. Many primary care facilities have integrated drug misuse screening and brief intervention (BI) into their usual care delivery. However, the efficacy of BI for drug misuse in primary...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahker, Ethan, Sakata, Masatsugu, Toyomoto, Rie, Hwang, Chiyoung, Yoshida, Kazufumi, Luo, Yan, Watanabe, Norio, Furukawa, Toshi A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470504/
https://www.ncbi.nlm.nih.gov/pubmed/32878757
http://dx.doi.org/10.1136/bmjopen-2019-036633
_version_ 1783578600393408512
author Sahker, Ethan
Sakata, Masatsugu
Toyomoto, Rie
Hwang, Chiyoung
Yoshida, Kazufumi
Luo, Yan
Watanabe, Norio
Furukawa, Toshi A
author_facet Sahker, Ethan
Sakata, Masatsugu
Toyomoto, Rie
Hwang, Chiyoung
Yoshida, Kazufumi
Luo, Yan
Watanabe, Norio
Furukawa, Toshi A
author_sort Sahker, Ethan
collection PubMed
description INTRODUCTION: Drug misuse is associated with significant global morbidity, mortality, economic costs and social costs. Many primary care facilities have integrated drug misuse screening and brief intervention (BI) into their usual care delivery. However, the efficacy of BI for drug misuse in primary care has not been substantiated through meta-analysis. The aim of this systematic review and meta-analysis is to determine the efficacy of BI for drug misuse in primary care settings. METHODS AND ANALYSIS: We will include all randomised controlled trials comparing primary care-delivered BI for drug misuse with no intervention or minimal screening/assessment and usual care. Primary outcomes are (1) drug use frequency scores and (2) severity scores at intermediate follow-up (4–8 months). We will retrieve all studies through searches in CENTRAL, Embase, MEDLINE and PsycINFO until 31 May 2020. The reference list will be supplemented with searches in trial registries (eg, www.clinicaltrials.gov) and through relevant existing study reference lists identified in the literature. We will conduct a random-effect pairwise meta-analysis for primary and secondary outcomes. We will assess statistical heterogeneity though visual inspection of a forest plot and calculate I (2) statistics. We will assess risk of bias using the Cochrane Risk of Bias Tool V.2 and evaluate the certainty of evidence through the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Sensitivity analyses will account for studies with control group variations and studies with a high risk of bias. If heterogeneity is present, subgroup analyses will consider patient variables of age, sex/gender, race/ethnicity, per cent insured, baseline severity and primary drug misused. ETHICS AND DISSEMINATION: This study will use published aggregate data and will not require ethical approval. Findings will be disseminated in a peer-reviewed journal.
format Online
Article
Text
id pubmed-7470504
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-74705042020-09-15 Efficacy of brief intervention for drug misuse in primary care facilities: systematic review and meta-analysis protocol Sahker, Ethan Sakata, Masatsugu Toyomoto, Rie Hwang, Chiyoung Yoshida, Kazufumi Luo, Yan Watanabe, Norio Furukawa, Toshi A BMJ Open Addiction INTRODUCTION: Drug misuse is associated with significant global morbidity, mortality, economic costs and social costs. Many primary care facilities have integrated drug misuse screening and brief intervention (BI) into their usual care delivery. However, the efficacy of BI for drug misuse in primary care has not been substantiated through meta-analysis. The aim of this systematic review and meta-analysis is to determine the efficacy of BI for drug misuse in primary care settings. METHODS AND ANALYSIS: We will include all randomised controlled trials comparing primary care-delivered BI for drug misuse with no intervention or minimal screening/assessment and usual care. Primary outcomes are (1) drug use frequency scores and (2) severity scores at intermediate follow-up (4–8 months). We will retrieve all studies through searches in CENTRAL, Embase, MEDLINE and PsycINFO until 31 May 2020. The reference list will be supplemented with searches in trial registries (eg, www.clinicaltrials.gov) and through relevant existing study reference lists identified in the literature. We will conduct a random-effect pairwise meta-analysis for primary and secondary outcomes. We will assess statistical heterogeneity though visual inspection of a forest plot and calculate I (2) statistics. We will assess risk of bias using the Cochrane Risk of Bias Tool V.2 and evaluate the certainty of evidence through the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Sensitivity analyses will account for studies with control group variations and studies with a high risk of bias. If heterogeneity is present, subgroup analyses will consider patient variables of age, sex/gender, race/ethnicity, per cent insured, baseline severity and primary drug misused. ETHICS AND DISSEMINATION: This study will use published aggregate data and will not require ethical approval. Findings will be disseminated in a peer-reviewed journal. BMJ Publishing Group 2020-09-02 /pmc/articles/PMC7470504/ /pubmed/32878757 http://dx.doi.org/10.1136/bmjopen-2019-036633 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Addiction
Sahker, Ethan
Sakata, Masatsugu
Toyomoto, Rie
Hwang, Chiyoung
Yoshida, Kazufumi
Luo, Yan
Watanabe, Norio
Furukawa, Toshi A
Efficacy of brief intervention for drug misuse in primary care facilities: systematic review and meta-analysis protocol
title Efficacy of brief intervention for drug misuse in primary care facilities: systematic review and meta-analysis protocol
title_full Efficacy of brief intervention for drug misuse in primary care facilities: systematic review and meta-analysis protocol
title_fullStr Efficacy of brief intervention for drug misuse in primary care facilities: systematic review and meta-analysis protocol
title_full_unstemmed Efficacy of brief intervention for drug misuse in primary care facilities: systematic review and meta-analysis protocol
title_short Efficacy of brief intervention for drug misuse in primary care facilities: systematic review and meta-analysis protocol
title_sort efficacy of brief intervention for drug misuse in primary care facilities: systematic review and meta-analysis protocol
topic Addiction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470504/
https://www.ncbi.nlm.nih.gov/pubmed/32878757
http://dx.doi.org/10.1136/bmjopen-2019-036633
work_keys_str_mv AT sahkerethan efficacyofbriefinterventionfordrugmisuseinprimarycarefacilitiessystematicreviewandmetaanalysisprotocol
AT sakatamasatsugu efficacyofbriefinterventionfordrugmisuseinprimarycarefacilitiessystematicreviewandmetaanalysisprotocol
AT toyomotorie efficacyofbriefinterventionfordrugmisuseinprimarycarefacilitiessystematicreviewandmetaanalysisprotocol
AT hwangchiyoung efficacyofbriefinterventionfordrugmisuseinprimarycarefacilitiessystematicreviewandmetaanalysisprotocol
AT yoshidakazufumi efficacyofbriefinterventionfordrugmisuseinprimarycarefacilitiessystematicreviewandmetaanalysisprotocol
AT luoyan efficacyofbriefinterventionfordrugmisuseinprimarycarefacilitiessystematicreviewandmetaanalysisprotocol
AT watanabenorio efficacyofbriefinterventionfordrugmisuseinprimarycarefacilitiessystematicreviewandmetaanalysisprotocol
AT furukawatoshia efficacyofbriefinterventionfordrugmisuseinprimarycarefacilitiessystematicreviewandmetaanalysisprotocol